Cargando…

Autoimmune Bullous Disease Quality of Life (ABQoL) questionnaire: Validation of the translated Persian version in pemphigus vulgaris

BACKGROUND: Autoimmune bullous diseases are a group of rare, chronic, blistering diseases, with pemphigus vulgaris (PV) being the most common type in Iran. Skin and mucosal involvement and therapy may have a dismal impact on the quality of life of affected patients. OBJECTIVE: We aimed to assess the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teimourpour, Amir, Hedayat, Kowsar, Salarvand, Fereshteh, Ghandi, Narges, Ghiasi, Maryam, Mahmoudi, Hamidreza, Balighi, Kamran, Toosi, Roja, Mohebi, Farnam, Nili, Ali, Daneshpazhooh, Maryam, Murrell, Dedee F., Chams-Davatchi, Cheyda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522916/ https://www.ncbi.nlm.nih.gov/pubmed/33015292 http://dx.doi.org/10.1016/j.ijwd.2020.03.043

Ejemplares similares

Koebner phenomenon in pemphigus vulgaris patients
por: Balighi, Kamran, et al.
Publicado: (2016)

Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies
por: Mohebi, Farnam, et al.
Publicado: (2020)

Family impact of pemphigus disease in an Iranian population using the Family Dermatology Life Quality Index
por: Ghodsi, S. Zahra, et al.
Publicado: (2020)

Anal Involvement in Pemphigus Vularis
por: Khezri, Somayeh, et al.
Publicado: (2013)

Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
por: Alaeen, Hoorieh, et al.
Publicado: (2019)

Indirect immunofluorescence on rat bladder epithelium in patients with pemphigus vulgaris with an extended follow‐up
por: Samadi, Mahsa, et al.
Publicado: (2022)

Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020)

Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire
por: Yang, Baoqi, et al.
Publicado: (2017)

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Evaluation of Vitamin D Status in Newly Diagnosed Pemphigus Vulgaris Patients
por: ZAREI, Mahnaz, et al.
Publicado: (2014)

Serum Selenium, Zinc, and Copper in Early Diagnosed Patients with Pemphigus Vulgaris
por: Javanbakht, MH, et al.
Publicado: (2012)

Kaposi's sarcoma in a patient with pemphigus vulgaris mimicking exacerbation of pemphigus
por: Balighi, Kamran, et al.
Publicado: (2023)

Evaluation of prolactin levels in patients with newly diagnosed pemphigus vulgaris and its correlation with pemphigus disease area index
por: Lajevardi, Vahideh, et al.
Publicado: (2016)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
por: Dehghanimahmoudabadi, Azin, et al.
Publicado: (2022)

Management of pemphigus
por: Daniel, Benjamin S., et al.
Publicado: (2014)

Dermoscopic Findings in 126 Patients with Alopecia Areata: A Cross-Sectional Study
por: Mahmoudi, Hamidreza, et al.
Publicado: (2018)

Infections in Hospitalized Patients with Psoriasis in a Skin Referral Hospital
por: Zaredar, Nafise, et al.
Publicado: (2023)

Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
por: Mahmoudi, Hamidreza, et al.
Publicado: (2021)

Validation studies of outcome measures in pemphigus()()()
por: Hanna, Sarah, et al.
Publicado: (2016)

The potential roles of herpesvirus and cytomegalovirus in the exacerbation of pemphigus vulgaris
por: Mohammadi, Fariba, et al.
Publicado: (2018)

Illness perception of patients with pemphigus vulgaris()
por: Nasimi, Maryam, et al.
Publicado: (2018)

Bruton Tyrosine Kinase Inhibition and Its Role as an Emerging Treatment in Pemphigus
por: Patsatsi, Aikaterini, et al.
Publicado: (2021)

Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
por: Mahmoudi, Hamidreza, et al.
Publicado: (2022)

Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II
por: Patsatsi, Aikaterini, et al.
Publicado: (2023)

Burden of pemphigus vulgaris with a particular focus on women: A review
por: Kianfar, Nika, et al.
Publicado: (2022)

New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: A review of the literature()()
por: Xuan, Rachel R., et al.
Publicado: (2018)

Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
por: Behkar, Atefeh, et al.
Publicado: (2022)

Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review
por: Zeng, Faith A.P., et al.
Publicado: (2022)

Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia
por: Koszegi, Ben, et al.
Publicado: (2023)

l‐carnitine downregulate the muscle wasting effect of glucocorticoids in pemphigus patient: A randomized double‐blind placebo‐controlled study
por: Noormohammadi, Zeinab, et al.
Publicado: (2023)

Salivary Desmoglein Enzyme-Linked Immunosorbent Assay for Diagnosis of Pemphigus Vulgaris: A Noninvasive Alternative Test to Serum Assessment
por: Mortazavi, Hossein, et al.
Publicado: (2015)

Longitudinal melanonychia in an Iranian population: a study of 96 patients
por: Kamyab, Kambiz, et al.
Publicado: (2016)

Detection of herpes simplex viruses in the oral lesions of patients with pemphigus vulgaris: Is it diagnostic or predictive of disease severity?
por: Kamyab, Kambiz, et al.
Publicado: (2023)

Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls
por: Shahbazian, Pegah, et al.
Publicado: (2021)

Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
por: Kianfar, Nika, et al.
Publicado: (2022)

Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL)
por: Hedayat, Kosar, et al.
Publicado: (2016)

Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination
por: Aryanian, Zeinab, et al.
Publicado: (2022)

MENTAL HEALTH IN PATIENTS WITH PEMPHIGUS: AN ISSUE TO WORTH CONSIDERATION
por: Arbabi, Mohammad, et al.
Publicado: (2011)

The Association Between Dietary Diversity Score and Cardiovascular Risk Factors Among Patients With Pemphigus Vulgaris: A Cross Sectional Study
por: Seifollahi, Atefeh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_134epfq5a9q6q93165a7e2e905